Companies: 10,795·Total market cap: $144.5T

Evogene Ltd.

Evogene Ltd.

EVGNNASDAQHealthcare● Active

$0.58

$-0.04(-5.82%)

Market Cap$5023607

P/E Ratio—

52W High$2.42

52W Low$0.52

Avg Volume509K

Open$0.61

Beta0.74

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Evogene Ltd.（EVGN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · EVGN · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.39Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$1.8MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding7.9MShares outstanding history

Next EarningsAug 26, 2026Est.Earnings history

探索 Evogene Ltd. 数据

分析师预测$2 · Buy

股息不分红

营收$3.9M-30.91%

盈利EPS $-1.08+62.63%

财务快照

FY 2025Revenue$3.9M▼ 30.91% YoY

202320242025

FY 2025Net Income-$8.5M▲ +48.53% YoY

202320242025

FY 2025EPS$-1.08▲ +62.63% YoY

202320242025

TTM:Revenue: $1.8MNet Income: -$11.8MEPS: $-1.39View income statement →

分析师评级与目标价

Buy4 位分析师

Strong Buy

0

Buy

4

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$2.15Low

$0.58Current

$2.15Avg Target上涨空间 268.78%

$2.15High

合计: 4 · 买入占比: 100.0%

根据过去 3 个月内 4 位华尔街分析师，EVGN 共识评级为 Buy，12 个月平均目标价 $2.15 （较现价 $0.58 上涨空间 268.78%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$0.58-5.82%$5.0M #2

AEON Biopharma, Inc.

$0.74+2.08%$8.7M #3

Bolt Biotherapeutics, Inc.

$4.72+3.51%$9.1M #4

$4.53+0.78%$25.4M #5

Cellectar Biosciences, Inc.

$2.51-3.09%$8.0M #6

Cocrystal Pharma, Inc.

$1.01+4.74%$10.4M

股票表现

1D-5.82%

1W-3.03%

1M-22.44%

3M-24.06%

YTD-47.00%

1Y-48.41%

5Y-98.52%

关于 Evogene Ltd.

CEOOfer Haviv

IPO DateOct 15, 2010

Employees117

CountryIL

Websiteevogene.com

Evogene Ltd. along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as h…

Biotechnology HealthcareNASDAQIL

关于股票概览与关键数据

Evogene Ltd.（EVGN）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 15, 2010 在 NASDAQ 上市。截至最近交易日，EVGN 股价为 $0.58，市值约为 $5.0M。过去12个月累计回报 -48.41%，年初至今回报 -47.00%。

根据 4 位华尔街分析师，Evogene Ltd. 股票共识评级为Buy，12个月平均目标价为 $2.15。2025 财年 Evogene Ltd. 营收 $3.9M，净利润 -$8.5M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Evogene Ltd.（EVGN）股价为 $0.58，在 NASDAQ 上市，52周区间为 $0.52 – $2.42。

EVGN 最新股价EVGN quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议